These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 37811585)

  • 21. Structural and functional characteristics of the SARS-CoV-2 Omicron subvariant BA.2 spike protein.
    Zhang J; Tang W; Gao H; Lavine CL; Shi W; Peng H; Zhu H; Anand K; Kosikova M; Kwon HJ; Tong P; Gautam A; Rits-Volloch S; Wang S; Mayer ML; Wesemann DR; Seaman MS; Lu J; Xiao T; Xie H; Chen B
    Nat Struct Mol Biol; 2023 Jul; 30(7):980-990. PubMed ID: 37430064
    [TBL] [Abstract][Full Text] [Related]  

  • 22. SARS-CoV-2 Evolution: On the Sudden Appearance of the Omicron Variant.
    Berkhout B; Herrera-Carrillo E
    J Virol; 2022 Apr; 96(7):e0009022. PubMed ID: 35293771
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Tracking the Genomic Evolution of SARS-CoV-2 for 29 Months in South Korea.
    Jeong S; Kim JS; Lee SK; Cho EJ; Hyun J; Song W; Kim HS
    Viruses; 2023 Mar; 15(4):. PubMed ID: 37112852
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The SARS-CoV-2 Delta-Omicron Recombinant Lineage (XD) Exhibits Immune-Escape Properties Similar to the Omicron (BA.1) Variant.
    Arora P; Zhang L; Rocha C; Graichen L; Nehlmeier I; Kempf A; Cossmann A; Ramos GM; Baier E; Tampe B; Moerer O; Dickel S; Winkler MS; Behrens GMN; Pöhlmann S; Hoffmann M
    Int J Mol Sci; 2022 Nov; 23(22):. PubMed ID: 36430535
    [TBL] [Abstract][Full Text] [Related]  

  • 25. An evolutionary insight into Severe Acute Respiratory Syndrome Coronavirus 2 Omicron variant of concern.
    Paz M; Aldunate F; Arce R; Ferreiro I; Cristina J
    Virus Res; 2022 Jun; 314():198753. PubMed ID: 35331836
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mutation and codon bias analysis of the spike protein of Omicron, the recent variant of SARS-CoV-2.
    Lu Y; Wang W; Liu H; Li Y; Yan G; Franzo G; Dai J; He WT
    Int J Biol Macromol; 2023 Oct; 250():126080. PubMed ID: 37536405
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Detection and Characterisation of SARS-CoV-2 in Eastern Province of Zambia: A Retrospective Genomic Surveillance Study.
    Shempela DM; Chambaro HM; Sikalima J; Cham F; Njuguna M; Morrison L; Mudenda S; Chanda D; Kasanga M; Daka V; Kwenda G; Musonda K; Munsaka S; Chilengi R; Sichinga K; Simulundu E
    Int J Mol Sci; 2024 Jun; 25(12):. PubMed ID: 38928045
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The Omicron variant of concern: Diversification and convergent evolution in spike protein, and escape from anti-Spike monoclonal antibodies.
    Focosi D; McConnell S; Casadevall A
    Drug Resist Updat; 2022 Dec; 65():100882. PubMed ID: 36260961
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Rapid Identification of SARS-CoV-2 Omicron BA.5 Spike Mutation F486V in Clinical Specimens Using a High-Resolution Melting-Based Assay.
    Aoki A; Adachi H; Mori Y; Ito M; Sato K; Kinoshita M; Kuriki M; Okuda K; Sakakibara T; Okamoto Y; Jinno H
    Viruses; 2022 Oct; 14(11):. PubMed ID: 36366499
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Virological characteristics of the SARS-CoV-2 Omicron BA.2 spike.
    Yamasoba D; Kimura I; Nasser H; Morioka Y; Nao N; Ito J; Uriu K; Tsuda M; Zahradnik J; Shirakawa K; Suzuki R; Kishimoto M; Kosugi Y; Kobiyama K; Hara T; Toyoda M; Tanaka YL; Butlertanaka EP; Shimizu R; Ito H; Wang L; Oda Y; Orba Y; Sasaki M; Nagata K; Yoshimatsu K; Asakura H; Nagashima M; Sadamasu K; Yoshimura K; Kuramochi J; Seki M; Fujiki R; Kaneda A; Shimada T; Nakada TA; Sakao S; Suzuki T; Ueno T; Takaori-Kondo A; Ishii KJ; Schreiber G; ; Sawa H; Saito A; Irie T; Tanaka S; Matsuno K; Fukuhara T; Ikeda T; Sato K
    Cell; 2022 Jun; 185(12):2103-2115.e19. PubMed ID: 35568035
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinical virology and effect of Covid-19 vaccination and monoclonal antibodies against highly infectious SARS- CoV-2 omicron sub variant BF.7 (BA.5.2.1.7): A systematic review.
    Chenchula S; Amerneni KC; Ghanta MK; Padmavathi R; Chandra MB; Adusumilli MB; Chavan M; Mudda S; Gupta R; Lakhawat B
    Virology; 2023 Jul; 584():38-43. PubMed ID: 37229914
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Challenges of the Omicron (B.1.1.529) Variant and Its Lineages: A Global Perspective.
    Mohapatra RK; Kandi V; Verma S; Dhama K
    Chembiochem; 2022 May; 23(9):e202200059. PubMed ID: 35322516
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The emergence and implications of SARS-CoV-2 omicron subvariant BA.2.86 on global health.
    Satapathy P; Kumar P; Gupta JK; Rabaan AA; Al Kaabi NA; Mohanty D; Naveen P; Khatib MN; Gaidhane S; Zahiruddin QS; Neyazi A
    Int J Surg; 2024 Apr; 110(4):2498-2501. PubMed ID: 38215252
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Genomic architecture and evolutionary relationship of BA.2.75: A Centaurus subvariant of Omicron SARS-CoV-2.
    Basheer A; Zahoor I; Yaqub T
    PLoS One; 2023; 18(5):e0281159. PubMed ID: 37224159
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Quantitative Mutation Analysis of Genes and Proteins of Major SARS-CoV-2 Variants of Concern and Interest.
    Liang F
    Viruses; 2023 May; 15(5):. PubMed ID: 37243278
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Editorial: The XBB.1.5 ('Kraken') Subvariant of Omicron SARS-CoV-2 and its Rapid Global Spread.
    Parums DV
    Med Sci Monit; 2023 Feb; 29():e939580. PubMed ID: 36722047
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Sequence analysis of the emerging SARS-CoV-2 variant Omicron in South Africa.
    Wang L; Cheng G
    J Med Virol; 2022 Apr; 94(4):1728-1733. PubMed ID: 34897752
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Omicron SARS-CoV-2 variant: Unique features and their impact on pre-existing antibodies.
    Kannan SR; Spratt AN; Sharma K; Chand HS; Byrareddy SN; Singh K
    J Autoimmun; 2022 Jan; 126():102779. PubMed ID: 34915422
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Emergence of SARS-CoV-2 Omicron lineages BA.4 and BA.5 in South Africa.
    Tegally H; Moir M; Everatt J; Giovanetti M; Scheepers C; Wilkinson E; Subramoney K; Makatini Z; Moyo S; Amoako DG; Baxter C; Althaus CL; Anyaneji UJ; Kekana D; Viana R; Giandhari J; Lessells RJ; Maponga T; Maruapula D; Choga W; Matshaba M; Mbulawa MB; Msomi N; ; Naidoo Y; Pillay S; Sanko TJ; San JE; Scott L; Singh L; Magini NA; Smith-Lawrence P; Stevens W; Dor G; Tshiabuila D; Wolter N; Preiser W; Treurnicht FK; Venter M; Chiloane G; McIntyre C; O'Toole A; Ruis C; Peacock TP; Roemer C; Kosakovsky Pond SL; Williamson C; Pybus OG; Bhiman JN; Glass A; Martin DP; Jackson B; Rambaut A; Laguda-Akingba O; Gaseitsiwe S; von Gottberg A; de Oliveira T
    Nat Med; 2022 Sep; 28(9):1785-1790. PubMed ID: 35760080
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A Heterologous Challenge Rescues the Attenuated Immunogenicity of SARS-CoV-2 Omicron BA.1 Variant in Syrian Hamster Model.
    Ma J; Liu X; Zhou M; Chen P; Chen R; Wang J; Zhu H; Wu K; Ye J; Zhang Y; Yuan Q; Tang Q; Yuan L; Cheng T; Guan Y; Xia N
    J Virol; 2023 Feb; 97(2):e0168422. PubMed ID: 36651747
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.